Burning Rock Biotech Ltd
BNR- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001792267
In the last 90 days, Burning Rock Biotech Ltd insiders filed 1 open-market purchase and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $16.5M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Burning Rock Biotech Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $6.18M in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$6.18M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Burning Rock Biotech Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Han Yusheng | Director | 18,404,086 | Jul 2, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 (view filing)8:30 AM ET | Jun 11-26 | 21 daysLate | Han YushengDirector | PPurchaseOrdinary Shares (represented by American depositary shares) | +731.4K | $8.45 | +$6.18M | +4.1%18.4M after | 7 lots |
| Apr 2, 2026 (view filing) | Mar 31 | 2 days | Han YushengDirector | PPurchaseOrdinary Shares (represented by American depositary shares) | +314.9K | $17.36 | +$5.47M | +1.8%17.7M after |